Investors , most notably Carl Icahn , were critical of the merger , saying that Mylan was overpaying for King .
Soon after , in July 2004 , a deal was made for Mylan Laboratories to acquire King for $4 billion .
Investors , most notably Carl Icahn , were critical of the merger , saying that Mylan Laboratories was overpaying for King .
Soon after , in July 2004 , a deal was made for Mylan Laboratories to acquire King for $4 billion .